TrialDrug design, development and therapy2017

An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis.

L S Martin-Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.